Betelehem W. Yacob

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts

Anna Capasso, Julie Lang, Todd M. Pitts et al. · Journal for ImmunoTherapy of Cancer · 2019 · 178 citations · Full text

Life Sciences, Immunology, Oncology +17

Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment

Julie Lang, Anna Capasso, Kimberly R. Jordan et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 60 citations · Full text

Medicine, Immunology, Oncology +17

BRAF fusions identified in melanomas have variable treatment responses and phenotypes

Jacqueline A. Turner, Judson Bemis, Stacey M. Bagby et al. · Oncogene · 2018 · 43 citations

Medicine, Cancer Biology, Oncology +14

First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer

Anna Capasso, Stacey M. Bagby, Kyrie L. Dailey et al. · Molecular Cancer Therapeutics · 2019 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer

John J. Tentler, Julie Lang, Anna Capasso et al. · BMC Cancer · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17